Oxibendazole

SKU: orb1300608

Description

Oxibendazole

Research Area

Cell Biology, Infectious Disease & Virology

Key Properties

• CAS Number: 20559-55-1
• MW: 249.27
• Purity: 99.90%
• Formula: C₁₂H₁₅N₃O₃
• SMILES: N(C(OC)=O)C=1NC=2C(N1)=CC(OCCC)=CC2
• Target: Parasite,Apoptosis
• Solubility: DMSO:30 mg/mL (120.35 mM);H2O:Insoluble

Bioactivity

• In Vivo:
  Oxibendazole shows a significant reduction of the proportion of positive foals after treatment. Oxibendazole significantly reduces the proportion of positive horse foals on six of the seven farms (86%). Oxibendazole reduces in the number of strongyle eggs/g (epg) in horse, but the reduction is only by 82% with an upper confidence limit of 89%. Oxibendazole results in collapse of the lip papillae, rupture of buccal cavity cuticle, prolapse of the pharynx, degeneration of epithelial cells and erosion of microvilli in adult Ascaris suum, theses changes may lead to impaired digestion and absorption of nutrients and cause cellular autolysis, resulting in the death of the worm. Oxibendazole reduces faecal worm egg counts (EPG) by 97.6% for Toxocara canis, 95.7% for Trichuris vulpis, 94.6% for Ancylostoma caninum, and 100% for Toxascaris leonine in dogs and cats. Oxibendazole could only be detected in plasma at the 0.5 hours and 1.0 hours post administration sampling times and the mean maximum plasma concentration is 0.008 mg/mL in horse. Oxibendazole is detected in faeces between 12 and 72 hours after administration and the highest dry faecal concentration was detected at 24 hours.

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Apoptosis, Parasite, Oxibendazole, Inhibitor, inhibit

Compound Identifiers

PubChem CID

4622